檢索結果 - Federico Cappuzzo
- Showing 1 - 20 results of 90
- Go to Next Page
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
Predictive biomarkers of immunotherapy for non-small cell lung cancer: results from an Experts Panel Meeting of the Italian Association of Thoracic Oncology 由 Cesare Gridelli, Andrea Ardizzoni, Massimo Barberis, Federico Cappuzzo, Francesca Casaluce, Romano Danesi, Giancarlo Troncone, Filippo de Marinis
出版 2017Revisão -
9
Survival benefit with erlotinib maintenance therapy in patients with advanced non-small-cell lung cancer (NSCLC) according to response to first-line chemotherapy 由 Bruno Coudert, Tudor‐Eliade Ciuleanu, K. Park, Yi‐Long Wu, Giuseppe Giaccone, Wolfram Brugger, P. Gopalakrishna, Federico Cappuzzo
出版 2011Artigo -
10
-
11
-
12
-
13
Gemcitabine and vinorelbine in pemetrexed‐pretreated patients with malignant pleural mesothelioma 由 Paolo Andrea Zucali, Giovanni Luca Ceresoli, I. Garassino, Fabio De Vincenzo, Raffaele Cavina, Elisabetta Campagnoli, Federico Cappuzzo, Silvia Salamina, Héctor Soto Parrà, Armando Santoro
出版 2008Artigo -
14
Let-7g and miR-21 expression in non-small cell lung cancer: Correlation with clinicopathological and molecular features 由 Alessandra Capodanno, Laura Boldrini, Agnese Proietti, Greta Alì, S Pelliccioni, Cristina Niccoli, Armida D’Incecco, Federico Cappuzzo, Antonio Chella, Marco Lucchi, Alfredo Mussi, Gabriella Fontanini
出版 2013Artigo -
15
EGFR fluorescence in situ hybridisation assay: guidelines for application to non-small-cell lung cancer 由 Marileila Varella‐Garcia, Joachim Diebold, David A. Eberhard, K Geenen, Astrid Hirschmann, Mark Kockx, Iris Nagelmeier, Josef Rüschoff, Martina Schmitt, Stefanie Arbogast, Federico Cappuzzo
出版 2009Artigo -
16
Prospective Molecular Marker Analyses of <i>EGFR</i> and <i>KRAS</i> From a Randomized, Placebo-Controlled Study of Erlotinib Maintenance Therapy in Advanced Non–Small-Cell Lung Ca... 由 Wolfram Brugger, Nadja Triller, Maria Błasińska-Morawiec, S. Curescu, Raimundas Sakalauskas, Georgy M. Manikhas, Julien Mazières, Renaud Whittom, Carol Ward, Karen Mayne, Kerstin Trunzer, Federico Cappuzzo
出版 2011Artigo -
17
A consensus on the role of osimertinib in non-small cell lung cancer from the AME Lung Cancer Collaborative Group 由 Tao Jiang, Chunxia Su, Shengxiang Ren, Federico Cappuzzo, Gaetano Rocco, Joshua D. Palmer, Nico van Zandwijk, Fiona Blackhall, Xiuning Le, Nathan A. Pennell, Caicun Zhou
出版 2018Revisão -
18
Correlation of cytidine deaminase polymorphisms and activity with clinical outcome in gemcitabine-/platinum-treated advanced non-small-cell lung cancer patients 由 Carmelo Tibaldi, Elisa Giovannetti, Marcello Tiseo, Leticia G. León, Armida D’Incecco, Nienke Loosekoot, Marco Bartolotti, Richard J. Honeywell, Federico Cappuzzo, Andrea Ardizzoni, Godefridus J. Peters
出版 2011Artigo -
19
TROPION-Lung08: phase III study of datopotamab deruxtecan plus pembrolizumab as first-line therapy for advanced NSCLC 由 Benjamin Levy, Enriqueta Felip, Martin Reck, James Chih‐Hsin Yang, Federico Cappuzzo, Yasuto Yoneshima, Caicun Zhou, Siddhartha Rawat, Jingdong Xie, Priyanka Basak, Lu Xu, Jacob Sands
出版 2023Artigo -
20
相關主題
Medicine
Internal medicine
Oncology
Cancer
Lung cancer
Biology
Epidermal growth factor receptor
Cancer research
Chemotherapy
Gene
Immunotherapy
Genetics
Gefitinib
Colorectal cancer
Confidence interval
Pathology
Cisplatin
Hazard ratio
KRAS
Adverse effect
Adenocarcinoma
Gastroenterology
Nivolumab
Clinical trial
Erlotinib
Atezolizumab
Environmental health
Immunohistochemistry
Population
Surgery